Show simple item record

dc.creatorLandovitz, Raphael J.
dc.creatorLi, Sue.
dc.creatorGrinsztejn, Beatriz.
dc.creatorDawood, Halima.
dc.creatorLiu, Albert Y.
dc.creatorMagnus, Manya.
dc.creatorHosseinipour, Mina C.
dc.creatorPanchia, Ravindre.
dc.creatorCottle, Leslie.
dc.creatorChau, Gordon.
dc.creatorRichardson, Paul.
dc.creatorMarzinke, Mark Albert.
dc.creatorHendrix, Craig W.
dc.creatorEshleman, Susan H.
dc.creatorZhang, Yinfeng.
dc.creatorTolley, Elizabeth E.
dc.creatorSugarman, Jeremy.
dc.creatorKofron, Ryan.
dc.creatorAdeyeye, Adeola.
dc.creatorBurns, David.
dc.creatorRinehart, Alex R.
dc.creatorMargolis, David.
dc.creatorSpreen, William R.
dc.creatorCohen, Myron S.
dc.creatorMcCauley, Marybeth.
dc.creatorEron, Joseph J.
dc.date.accessioned2019-12-15T15:43:36Z
dc.date.available2019-12-15T15:43:36Z
dc.date.created2018
dc.date.issued2018
dc.identifier.citationLandovitz, R.J., Li, S., Grinsztejn, B., Dawood, H., Liu, A.Y., Magnus, M., Hosseinipour, M.C., Panchia, R., Cottle, L., Chau, G., Richardson, P., Marzinke, M., Hendrix, C.W., Eshleman, S.H., Zhang, Y., Tolley, E., Sugarman, J., Kofron, R., Adeyeye, A., Burns, D., Rinehart, A.R., Margolis, D., Spreen, W.R., Cohen, M.S., McCauley, M.and Eron, J.J. 2018. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Medicine 15(11), e1002690.en_US
dc.identifier.urihttp://dx.doi.org/10.1371/journal.pmed.1002690en_US
dc.identifier.urihttps://researchspace.ukzn.ac.za/handle/10413/16641
dc.descriptionCAPRISA, 2018.en_US
dc.description.abstractAbstract available in pdf.en_US
dc.language.isoenen_US
dc.publisherPublic Library of Science.en_US
dc.subjectAdolescent.en_US
dc.subjectAdult.en_US
dc.subjectAnti-HIV Agents/adverse effects.en_US
dc.subjectAnti-HIV Agents/blood.en_US
dc.subjectAnti-HIV Agents/pharmacokinetics.en_US
dc.titleSafety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record